Literature DB >> 8243486

Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients.

F Blasi1, R Cosentini, D Legnani, F Denti, L Allegra.   

Abstract

The incidence of Chlamydia pneumoniae as a cause of community-acquired pneumonia was evaluated in a one-year prospective study in 108 patients with community-acquired pneumonia. The bacteriological diagnosis was based on culture of sputum or bronchial aspirate and examination of acute and convalescent phase sera for Mycoplasma pneumoniae, Legionella pneumophila and Chlamydia pneumoniae. A definitive microbiological diagnosis was obtained in 58 (54%) patients. Chlamydia pneumoniae was the causative agent in 14 patients (13%) on the basis of positive serological tests; in 10 of the 14 patients Chlamydia pneumoniae was also detected by means of an indirect immunofluorescence test using pharyngeal swab specimens. In conclusion, Chlamydia pneumoniae seems to be a common etiological agent of community-acquired pneumonia, as increasingly reported in the last six to seven years.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8243486     DOI: 10.1007/bf02009382

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  15 in total

Review 1.  TWAR and changing respiratory infections.

Authors:  G Ridgway
Journal:  Practitioner       Date:  1990-08

Review 2.  Chlamydia pneumoniae, strain TWAR.

Authors:  J T Grayston
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

Review 3.  Community-acquired pneumonia: the clinical dilemma.

Authors:  D L Bowton; D A Bass
Journal:  J Thorac Imaging       Date:  1991-07       Impact factor: 3.000

4.  Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma.

Authors:  D L Hahn; R W Dodge; R Golubjatnikov
Journal:  JAMA       Date:  1991-07-10       Impact factor: 56.272

5.  Community-acquired pneumonia. Importance of initial noninvasive bacteriologic and radiographic investigations.

Authors:  M Lévy; F Dromer; N Brion; F Leturdu; C Carbon
Journal:  Chest       Date:  1988-01       Impact factor: 9.410

Review 6.  Infections with Chlamydia pneumoniae strain TWAR.

Authors:  D H Thom; J T Grayston
Journal:  Clin Chest Med       Date:  1991-06       Impact factor: 2.878

7.  Community-acquired pneumonia requiring hospitalization: 5-year prospective study.

Authors:  T J Marrie; H Durant; L Yates
Journal:  Rev Infect Dis       Date:  1989 Jul-Aug

8.  Chlamydia pneumoniae infection in acute exacerbations of COPD.

Authors:  F Blasi; D Legnani; V M Lombardo; G G Negretto; E Magliano; R Pozzoli; F Chiodo; A Fasoli; L Allegra
Journal:  Eur Respir J       Date:  1993-01       Impact factor: 16.671

9.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.

Authors:  J T Grayston; C C Kuo; S P Wang; J Altman
Journal:  N Engl J Med       Date:  1986-07-17       Impact factor: 91.245

10.  Epidemiology of community-acquired respiratory tract infections in adults. Incidence, etiology, and impact.

Authors:  R A Garibaldi
Journal:  Am J Med       Date:  1985-06-28       Impact factor: 4.965

View more
  8 in total

1.  Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.

Authors:  Jacques Gaillat; Antoine Flahault; Bertille deBarbeyrac; Jeanne Orfila; Henri Portier; Jean-Pierre Ducroix; Christiane Bébéar; Charles Mayaud
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  Prospective study of epidemiology and prognostic factors in community-acquired pneumonia.

Authors:  J Gómez; V Baños; J Ruiz Gómez; M C Soto; L Muñoz; M L Nuñez; M Canteras; M Valdés
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-07       Impact factor: 3.267

3.  Polymerase chain reaction for detection of Chlamydia pneumoniae in gargled-water specimens of children.

Authors:  P M Prückl; C Aspöck; A Makristathis; M L Rotter; H Wank; B Willinger; A M Hirschl
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1995-02       Impact factor: 3.267

4.  Prevalence of antibodies to Chlamydia pneumoniae in Slovenia.

Authors:  D Kese; H Hren-Vencelj; M Socan; B Beovic; M Cizman
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-06       Impact factor: 3.267

5.  Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients.

Authors:  D Lieberman; M Ben-Yaakov; Z Lazarovich; A Porath; F Schlaeffer; D Lieberman; M Leinonen; P Saikku; O Horovitz; I Boldur
Journal:  Infection       Date:  1996 Mar-Apr       Impact factor: 3.553

6.  Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus.

Authors:  U V Comandini; P Maggi; P Santopadre; R Monno; G Angarano; V Vullo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

7.  Clinical features of Chlamydia pneumoniae acute respiratory infection.

Authors:  Francesco Blasi
Journal:  Clin Microbiol Infect       Date:  1996-03       Impact factor: 8.067

Review 8.  Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus.

Authors:  Daniel M Musher; Michael S Abers; John G Bartlett
Journal:  Clin Infect Dis       Date:  2017-10-30       Impact factor: 9.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.